Steve Aselage is a director of Acer Therapeutics Inc.
Person profile
Roles
Address
Fremont, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BIOCRYST PHARMACEUTICALS INC
14 Jun 24
4
BIOCRYST PHARMACEUTICALS INC
29 May 24
4
Acer Therapeutics Inc.
20 Nov 23
4
BIOCRYST PHARMACEUTICALS INC
15 Jun 23
4
Acer Therapeutics Inc.
16 Mar 23
4
Acer Therapeutics Inc.
1 Dec 22
4
BIOCRYST PHARMACEUTICALS INC
9 Jun 22
4
BIOCRYST PHARMACEUTICALS INC
2 Jun 22
4
Travere Therapeutics, Inc.
12 May 22
4
BIOCRYST PHARMACEUTICALS INC
2 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jun 24 | BCRX BioCryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 6,820 | 0.00 | 70,159 |
12 Jun 24 | BCRX BioCryst Pharmaceuticals | Automatic Stock Option Grant Common Stock | Grant | Acquire A | No | No | 6.3 | 49,933 | 314.58 k | 49,933 |
24 May 24 | BCRX BioCryst Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 6.4 | 2,500 | 16.00 k | 2,500 |
17 Nov 23 | ACER Acer Therapeutics | Common Stock, $0.0001 par value per share | Sale back to company | Dispose D | No | No | 0 | 483,741 | 0.00 | 0 |
13 Jun 23 | BCRX BioCryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 16,745 | 0.00 | 63,339 |
13 Jun 23 | BCRX BioCryst Pharmaceuticals | Automatic Stock Option Grant Common Stock | Grant | Acquire A | No | No | 8.18 | 39,072 | 319.61 k | 39,072 |